NKTR ▼ -2.3% - Nektar Therapeutics $NKTR NKTR - Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Nektar Therapeutics shares declined 2.3% following the company's announcement of inducement grants issued under Nasdaq listing rules. The company disclosed equity grants to new employees as part of their hiring practices, which is a routine corporate governance disclosure. The stock's modest decline likely reflects general market sentiment rather than any negative development, as inducement grants are a standard recruitment tool and regulatory requirement to disclose. 28-AUG-2026 04:15 PM ET